These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 25795074)

  • 1. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
    Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP;
    Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Fractalkines and Cardiovascular Outcomes in the CRIC Study Cohort.
    Yang P; Xu G
    Am J Kidney Dis; 2016 Feb; 67(2):342. PubMed ID: 26802332
    [No Abstract]   [Full Text] [Related]  

  • 4. In Reply to 'Serum Fractalkines and Cardiovascular Outcomes in the CRIC Study Cohort'.
    Shah R
    Am J Kidney Dis; 2016 Feb; 67(2):342. PubMed ID: 26802331
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
    Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
    Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
    Lash JP; Ricardo AC; Roy J; Deo R; Fischer M; Flack J; He J; Keane M; Lora C; Ojo A; Rahman M; Steigerwalt S; Tao K; Wolf M; Wright JT; Go AS;
    Am J Kidney Dis; 2016 Oct; 68(4):545-553. PubMed ID: 27209443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.
    Rahman M; Xie D; Feldman HI; Go AS; He J; Kusek JW; Lash J; Miller ER; Ojo A; Pan Q; Seliger SL; Steigerwalt S; Townsend RR;
    Am J Nephrol; 2014; 40(5):399-407. PubMed ID: 25401485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
    Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study.
    Toth-Manikowski SM; Yang W; Appel L; Chen J; Deo R; Frydrych A; Krousel-Wood M; Rahman M; Rosas SE; Sha D; Wright J; Daviglus ML; Go AS; Lash JP; Ricardo AC;
    Am J Kidney Dis; 2021 Aug; 78(2):200-209.e1. PubMed ID: 33857532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.
    Viazzi F; Garneri D; Leoncini G; Gonnella A; Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Agabiti Rosei E; Deferrari G; Pontremoli R
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):921-7. PubMed ID: 24675005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
    Chen J; Budoff MJ; Reilly MP; Yang W; Rosas SE; Rahman M; Zhang X; Roy JA; Lustigova E; Nessel L; Ford V; Raj D; Porter AC; Soliman EZ; Wright JT; Wolf M; He J;
    JAMA Cardiol; 2017 Jun; 2(6):635-643. PubMed ID: 28329057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
    Lucove J; Vupputuri S; Heiss G; North K; Russell M
    Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
    Amdur RL; Feldman HI; Dominic EA; Anderson AH; Beddhu S; Rahman M; Wolf M; Reilly M; Ojo A; Townsend RR; Go AS; He J; Xie D; Thompson S; Budoff M; Kasner S; Kimmel PL; Kusek JW; Raj DS;
    Am J Kidney Dis; 2019 Mar; 73(3):344-353. PubMed ID: 30545708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project.
    Guo Y; Apostalakis S; Blann AD; Lip GY
    Cerebrovasc Dis; 2014; 38(3):204-11. PubMed ID: 25301077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.
    Cheng HT; Huang JW; Chiang CK; Yen CJ; Hung KY; Wu KD
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1268-76. PubMed ID: 22337909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.